Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00127829
Status:
COMPLETED
Last Update Posted:
2009-04-23
First Post:
2005-08-05
Brief Title:
Study Evaluating Gefitinib IRESSA in Subjects With Solid Malignancies That Are Locally Advanced Recurrent or Metastatic
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Organization Data
Organization:
AstraZeneca
Class:
INDUSTRY
Study ID:
D7913C00022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AstraZeneca
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Alison Armour MD IRESSA Medical Science Director
Old Organization:
AstraZeneca